8 reports

The prominent features of this report are - ##.

  • Antimalarials
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative

The molecules developed by Companies in Phase III, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Antimalarials
  • Pharmaceutical
  • World
  • Product Initiative
  • Santen Pharmaceutical Co., Ltd.

Similarly, the Universities' portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Antimalarials
  • Therapy
  • Vaccine
  • United States
  • World

The molecules developed by Companies in Phase III, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Antimalarials
  • Pharmaceutical
  • World
  • Product Initiative
  • Santen Pharmaceutical Co., Ltd.

The prominent features of this report are - ##.

  • Antimalarials
  • Drug Discovery And Development
  • Neurology
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antimalarials
  • Drug Discovery And Development
  • Infectious Disease
  • World
  • GlaxoSmithKline plc

The molecules developed by Companies in Phase II, Phase I and Preclinical stages are ##, ## and ## respectively.

  • Antimalarials
  • Therapy
  • United States
  • World
  • Product Initiative

IN DECEMBER 2014, THE COMPANY RECEIVED FDA APPROVAL TO GRANIX (TBO-FILGRASTIM) INJECTION FOR SELF-ADMINISTRATION.

  • Antimalarials
  • North America
  • United States
  • Mylan Inc.
  • Pfizer Inc.